1,0
25 mar 2021
Dipendente attuale, più di 3 anni
Philadelphia, PA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Ken Fraizer, but he is leaving,
Svantaggi
People are vicious, ruthlessly competitive and power hungry. Bullying is accepted. Zero work life-balance in oncology. Painfully hierarchal. Process driven to the point where it stunts growth. Med-legal review process (Regulatory and Legal) is culturally toxic.